For Researchers
The Carolina Endometrial Cancer Study (CECS) provides important data for integrating tumor biology, lifestyle, social environment, cancer treatment, and other factors to identify contributors to outcomes, especially racial disparities, and inform potential areas for intervention or development.
Study Design
The CECS is a prospective cohort that uses rapid case ascertainment in collaboration with the North Carolina Central Cancer Registry to identify women with newly diagnosed endometrial cancer living in North Carolina. Enrollment began in January 2021 and is ongoing. Eligible participants are sampled to recruit 100% of African American women with an endometrial cancer diagnosis, and an age- and region- matched sample of White women. Endometrial cancer survivors of other races are sampled at their relative distribution within North Carolina.
Recruitment Eligibility
- Female adults aged 20 to 80 at time of diagnosis
- All racial and ethnic groups
- Are fluent in English
- Residents of any of the 100 counties of North Carolina at time of diagnosis
- Newly diagnosed with endometrial cancer since January 1, 2020
Informed Consent
All participants provided informed consent in either English prior to participation. CECS consent materials can be accessed below:
Consent to Participate in Research – CECS
Consent for Biological Specimens – Saliva/Tumor
Consent Addendum for Unencrypted Communication
Consent To Participate in Research – Home Visit Sub-Study
Consent for Biological Specimens – Stool/Vaginal
Questionnaires
Participants are asked to complete surveys on factors related to endometrial cancer risk and prognosis, survivorship, and recurrence at enrollment and approximately 18- and 36-months after diagnosis. Annotated survey instruments and can be accessed below:
Home Visit Pilot Questionnaire
Medical Records
Participants are asked for consent to retrieve medical records for initial endometrial cancer treatment and any recurrence. Medical record abstraction forms can be accessed below:
Medical Record Abstraction Form
Medical Records Abstraction Data Dictionary
Biospecimens
Participants are asked for consent to obtain tumor samples from their initial endometrial cancer diagnosis and to provide a mail-based saliva sample for germline DNA. A subset of 50 CECS participants within 90 miles of UNC additionally provided self-sampled gut and vaginal microbiome samples as part of a pilot study. Detailed information can be found here: https://unclineberger.org/cecs/biospecimens/
Centralized Pathology Review Form
Centralized Pathology Review Data Dictionary
Approved Project List
If you are interested in using CECS data for your project, please complete the following forms and email to cecs@unc.edu.
Authorship Proposal Guidelines Form
Title | Investigator(s) | Institution | Approved | |
Assessing Financial Toxicity and Quality of Life in Endometrial Cancer Survivors: A Secondary Analysis of the Carolina Endometrial Cancer Study | Megan Wohlfarth | UNC-Chapel Hill | 01/24/2024 | |
Lymphedema self-assessment among endometrial cancer survivors | Jordyn Brown | UNC-Chapel Hill | 02/20/2024 | |
Multilevel social determinants of health-related quality of life among endometrial cancer survivors in North Carolina | Jordyn Brown | UNC-Chapel Hill | 02/20/2024 | |
Pre-Diagnosis Symptoms Reported Among Endometrial Cancer Survivors | Meredith Wise | UNC-Chapel Hill | 04/29/2024 | |